This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd., Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 2 Years Active: 2026
Title: Jian Ge - Innovator in Ophthalmic Biotechnology
Introduction: Jian Ge is an accomplished inventor based in Guangzhou, China. He has made significant contributions to the field of ophthalmic biotechnology, particularly through his work with various companies. Although he currently holds no granted patents, his innovative spirit is evident in his latest patent applications.
Latest Patent Applications: Jian Ge's recent patent applications include two notable projects. The first is titled "Salt Form of Isoquinolinone Type Compound as ROCK Inhibitor and Preparation Method Therefor." This application discloses a salt form of an isoquinolinone type compound that acts as a ROCK protein kinase inhibitor. It also details the use of this compound in the preparation of a medicament for treating glaucoma or ocular hypertension. The second application is "Preparation and Expansion Methods for Human Pluripotent Stem Cell-Derived Human Retinal Pigment Epithelial Cells." This application outlines methods for preparing and expanding human retinal pigment epithelial cells derived from human pluripotent stem cells, which are crucial for advancing treatments in ophthalmology.
Conclusion: Jian Ge's work in ophthalmic biotechnology showcases his dedication to innovation and research. His latest patent applications reflect his commitment to developing new solutions for eye health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile